Migraine: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

• All targets
• CGRP 19
• HMGB1 0
• NOTCH3 0
• GLP-1 0
• MAPK 0
• PI3K 0
• IL-17 0
• IL-6 1
• TNF 1
• PPAR 0
• TREM2 0
• COX-2 0
• IL-4 0
• STING 0
• AKT 0
• AMPK 0
• AQP4 0
• ERK 0
• GIP 0
• GPX4 0
• HIF-1 0
• IL-1 1
• mTOR 0
• NLRP3 0
• NMDA 0
• PD-1 0
• SCN1A 0
• SCN2A 0
• STAT3 0
• VEGF 0

EU-13 is a filter, not a ranking: it only narrows the list.

16 of 16+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Terminated

  Acute Migraine Treatment in the ED With Gepants

  NCT06985342· Icahn School of Medicine at Mount Sinai· Updated 29 Apr 2026

  “Study closing at current site. Study to start as new at different site.”Registry text, quoted unchanged. Source

• Withdrawn

  A Study to Learn About Zavegepant as a Treatment for Multiple Migraine Attacks in Adult Participants

  NCT06103734· Pfizer· Updated 13 Jan 2026

  “Strategic decision to cancel the study based on adjusted clinical development plan.”Registry text, quoted unchanged. Source

• Terminated

  A Study With Intranasal Kinetic Oscillation Stimulation (KOS) in the Prevention of Chronic Migraine

  NCT05273151· Chordate Medical· Updated 31 Jul 2025

  “Slow inclusion due to new treatment (Gepants)”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• A Study to Learn About Zavegepant as a Treatment for Multiple Migraine Attacks in Adult Participants

  NCT06103734· Pfizer· Source

• Induction of Migraine Attacks With Aura Using Calcitonin Gene-Related Peptide

  NCT07021859· Danish Headache Center· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 7
• Mendelian Randomization Analysis 33
• Gene Expression Profiling 8
• Sequence Analysis, RNA 2
• Exome Sequencing 5
• Proteomics 6
• Metabolomics 6
• Mass Spectrometry 1
• Xenograft Model Antitumor Assays 2
• Positron-Emission Tomography 3
• Magnetic Resonance Imaging 136
• Machine Learning 32
• Deep Learning 1
• Cohort Studies 82
• Genome-Wide Association Study 40

• Integrating Metabolomics and Machine Learning Reveals Metabolic Signatures and Candidate Biomarkers for Vestibular Migraine.

  J Proteome Res, Oct 2026

• Migraine attack prediction using wearable biosensor data.

  Cephalalgia, Sept 2026

• Machine Learning-Guided Video Analysis Identifies Sound-Evoked Pain-Related Behaviors from Facial Grimace and Body Cues in Mice.

  eNeuro, Sept 2026

• Characterizing the clinical profile of primary headache using explainable artificial intelligence.

  Cephalalgia, Aug 2026

• Explainable machine learning reveals threshold associations and distinct phenotypes linking migraine features to white matter hyperintensities in women with episodic migraine.

  J Headache Pain, Aug 2026

• From uniformity to individuality: Computational modelling provides a mechanistic rationale for weight-adjusted botulinum neurotoxin a dosing.

  Toxicon, Jul 2026

• Prediction of migraine treatment response with clinical and genetic data: A machine learning analysis of the HUNT study.

  Cephalalgia, Jul 2026

• Personalized machine learning prediction of next-day migraine persistence using digital headache diary data.

  Headache, Jul 2026

• Vestibular cortex-related effective connectivity signatures: characterization and differentiation of vestibular migraine patients via magnetic resonance imaging and machine learning.

  J Headache Pain, Jun 2026

• Machine Diagnostics and Machine Phenotyping of Migraine: A HUNT Study.

  Neurology, Jun 2026

See which targets of this disease your abstract mentions, and go to the people working on them.